Tetrapyrrole photosensitisers, determinants of subcellular localisation and mechanisms of photodynamic processes in therapeutic approaches

Bibliography

• Spikes JD. Photodynamic reactions in photomedicine. In: Regan JD, Parrish JA, editors, The science of photomedicine. New York: Plenum Press; 1982. p. 113-44
   Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90(12):889-905
   PubMed Web of Science ®Google Scholar
• Allergan, Inc. Photodynamic therapy for pre-melanomas. WO3077911; 2003
   Google Scholar
• QLT, Inc.; Rubinchik V, Visser MD. Photodynamic therapy for the treatment of prostatic conditions. WO2005077457; 2005
   Google Scholar
• The Trustees of the University of Pennsylvania. Photodynamic therapy-generated mesothelioma vaccine. WO2007133728; 2007
   Google Scholar
• Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology. Ophthalmology 2000;107(12):2314-7
   PubMedGoogle Scholar
• QLT, Inc., Novartis AG; Strong HA, Ali MA, Reaves TA Jr. Method to prevent vision loss. WO02062385; 2002
   Google Scholar
• Massachusetts Eye, Ear Infirmary; Poulaki V, Miller JW, Gragoudas ES. Methods and compositions for treating conditions of the eye. WO2007097839; 2007
   Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3(5):380-7
   PubMed Web of Science ®Google Scholar
• Moan J, Pettersen EO, Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br J Cancer 1979;39(4):398-407
   PubMed Web of Science ®Google Scholar
• Niedre MJ, Secord AJ, Patterson MS, Wilson BC. In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res 2003;63(22):7986-94
   PubMedGoogle Scholar
• Health Research, Inc. New photosensitizing agents. WO9000895; 1990
   Google Scholar
• Figge FH, Barnett DJ. Anatomic evaluation of a jet injection instrument designed to minimize pain and inconvenience of parenteral therapy. Am Pract Dig Treat 1948;3(4):197-206
   PubMedGoogle Scholar
• Moan J, Peng Q. An outline of the history of PDT. In: Patrice T, editor, Photodynamic therapy. RSC; 2003. p. 1-17
   Google Scholar
• Dougherty TJ. Activated dyes as antitumor agents. J Natl Cancer Inst 1974;52(4):1333-6
   PubMedGoogle Scholar
• Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978;38(8):2628-35
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Lawrence G, Kaufman JH, et al. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979;62(2):231-7
   PubMed Web of Science ®Google Scholar
• Health Research, Inc. In situ photodynamic therapy. US5257970; 1993
   Google Scholar
• Lipson RL, Baldes EJ. The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol 1960;82:508-16
   PubMed Web of Science ®Google Scholar
• Oncology Research & Development, Inc. Purified hematoporphyrin derivative for diagnosis and treatment of tumors and method. WO8401382; 1984
   Google Scholar
• Wayne State University. Hematoporphyrin derivative and method of preparation and purification. US4861876; 1989
   Google Scholar
• Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy. US5190966; 1993
   Google Scholar
• Baas P, van Mansom I, van Tinteren H, et al. Effect of N-acetylcysteine on Photofrin-induced skin photosensitivity in patients. Lasers Surg Med 1995;16(4):359-67
   PubMed Web of Science ®Google Scholar
• Orenstein A, Kostenich G, Roitman L, et al. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Br J Cancer 1996;73(8):937-44
   PubMedGoogle Scholar
• Hahn SM, Putt ME, Metz J, et al. Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin Cancer Res 2006;12(18):5464-70
   PubMedGoogle Scholar
• Kessel D, Thompson P. Purification and analysis of hematoporphyrin and hematoporphyrin derivative by gel exclusion and reverse-phase chromatography. Photochem Photobiol 1987;46(6):1023-5
   PubMed Web of Science ®Google Scholar
• Mojzisova H, Bonneau S, Brault D. Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells. Eur Biophys J 2007;36(8):943-53
   PubMedGoogle Scholar
• Boyle RW, Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 1996;64(3):469-85
   PubMed Web of Science ®Google Scholar
• Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001;74(5):656-69
   PubMed Web of Science ®Google Scholar
• The University of British Columbia. Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents. US4920143; 1990
   Google Scholar
• The University of British Columbia. Benzoporphyrin derivatives for photodynamic. US5214036; 1993
   Google Scholar
• The Liposome Company, Inc. Benzoporphyrin vesicles and their use in photodynamic therapy. US5389378; 1995
   Google Scholar
• The University of British Columbia. Photoactive benzoporphyrin derivatives. EP1380586; 2004
   Google Scholar
• Richter AM, Jain AK, Canaan AJ, et al. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA). Biochem Pharmacol 1992;43(11):2349-58
   PubMedGoogle Scholar
• The University of British Columbia, Macalpine J, Dolphin D. Improved beta, beta,-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins. WO0061584; 2000
   Google Scholar
• Ceramoptec Industries, Inc. Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture. US2003023081; 2003
   Google Scholar
• Health Research, Inc. Water soluble tetrapyrollic photosensitizers for photodynamic therapy. US2007149497; 2007
   Google Scholar
• Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J 1989;261(1):277-80
   PubMedGoogle Scholar
• Hamari Yakuhin Kogyo Kabushiki Kaisha (Hamari Chemicals Ltd). Pheophorbide derivatives. EP0322198; 1989
   Google Scholar
• Health Research, Inc. Photosensitizing agents. US5002962; 1991
   Google Scholar
• Health Research, Inc. Pyropheophorbides and their use inphotodynamic therapy. EP1146046; 2001
   Google Scholar
• Koudinova NV, Pinthus JH, Brandis A, et al. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int J Cancer 2003;104(6):782-9
   PubMed Web of Science ®Google Scholar
• University Hospitals of Cleveland. Novel methods of syntheses of phthalocyanine compounds. WO9814521; 1998
   Google Scholar
• Photopharmica Limited. Photosensitisers. WO0224226; 2002
   Google Scholar
• Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Hammer R, Soper SA. Tetrazaporphyrin-based compounds and their uses. WO2007009101; 2007
   Google Scholar
• Laptev VP, Petrov VV, Andreev SM, et al. Pharmaceutical composition for photodynamic therapy and a method for treating oncological diseases by using said composition. WO2007075119; 2007
   Google Scholar
• Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995;24:19-33
   Web of Science ®Google Scholar
• Brasseur N, Ali H, Langlois R, van Lier JE. Biological activities of phthalocyanines - IX. Photosensitization of V-79 Chinese hamster cells and EMT-6 mouse mammary tumor by selectively sulfonated zinc phthalocyanines. Photochem Photobiol 1988;47(5):705-11
   PubMed Web of Science ®Google Scholar
• Reddi E, Zhou C, Biolo R, et al. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990;61(3):407-11
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6(1-2):143-8
   PubMed Web of Science ®Google Scholar
• Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-56
   PubMed Web of Science ®Google Scholar
• Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1993;1154(3-4):237-82
   PubMed Web of Science ®Google Scholar
• Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995;270(32):18997-9007
   PubMed Web of Science ®Google Scholar
• Wu M. Enhancement of immunotoxin activity using chemical and biological reagents. Br J Cancer 1997;75(9):1347-55
   PubMed Web of Science ®Google Scholar
• Berg K, Selbo PK, Prasmickaite L, et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res 1999;59(6):1180-3
   PubMed Web of Science ®Google Scholar
• The Norwegian Radium Hospital Research Foundation; Jones E, Berg K, Prasmickaite L, et al. Photochemical internalization for delivery of molecules into the cytosol. WO0244396; 2002
   Google Scholar
• Berg K, Prasmickaite L, Selbo PK, et al. Photochemical internalization (PCI) – a novel technology for release of macromolecules from endocytic vesicles. Oftalmologia 2003;56(1):67-71
   PubMedGoogle Scholar
• Photocure AS. Transfer of molecules into the cytosol of cells US2003134813; 2003
   Google Scholar
• Berg K, Folini M, Prasmickaite L, et al. Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol 2007;8(6):362-72
   PubMed Web of Science ®Google Scholar
• Selbo PK, Sivam G, Fodstad O, et al. In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. Int J Cancer 2001;92(5):761-6
   PubMed Web of Science ®Google Scholar
• Dietze A, Bonsted A, Hogset A, Berg K. Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells. Photochem Photobiol 2003;78(3):283-9
   PubMed Web of Science ®Google Scholar
• Dietze A, Peng Q, Selbo PK, et al. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. Br J Cancer 2005;92(11):2004-9
   PubMedGoogle Scholar
• Hamamatsu Photonics KK. Method of photodynamic diagnosis for vascular diseases. EP1847267; 2007
   Google Scholar
• Kodesh SA, Eren D, Mazor N. Tetraarylporphine derivatives and uses thereof. WO2008018063; 2008
   Google Scholar
• Yeda Research and Development Co. Ltd.; Scherz A, et al. Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses. WO2008023378; 2008
   Google Scholar
• Zimmermann A, Ritsch-Marte M, Kostron H. mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol 2001;74(4):611-6
   PubMedGoogle Scholar
• Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med 2006;38(5):522-31
   PubMed Web of Science ®Google Scholar
• Fritsch C, Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol 2006;25(1-2):425-39
   PubMed Web of Science ®Google Scholar
• Malik E, Berg C, Meyhofer-Malik A, et al. Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. Surg Endosc 2000;14(5):452-5
   PubMed Web of Science ®Google Scholar
• Bourg-Heckly G, Blais J, Padilla JJ, et al. Endoscopic ultraviolet-induced autofluorescence spectroscopy of the esophagus: tissue characterization and potential for early cancer diagnosis. Endoscopy 2000;32(10):756-65
   PubMedGoogle Scholar
• Bellnier DA, Dougherty TJ. A preliminary pharmacokinetic study of intravenous Photofrin in patients. J Clin Laser Med Surg 1996;14(5):311-4
   PubMedGoogle Scholar
• Jones HJ, Vernon DI, Brown SB. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. Br J Cancer 2003;89(2):398-404
   PubMedGoogle Scholar
• Brun PH, DeGroot JL, Dickson EF, et al. Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy. Photochem Photobiol Sci 2004;3(11-12):1006-10
   PubMedGoogle Scholar
• Bellnier DA, Ho YK, Pandey RK, et al. Distribution and elimination of photofrin II in mice. Photochem Photobiol 1989;50(2):221-8
   PubMed Web of Science ®Google Scholar
• Chan WS, Marshall JF, Svensen R, et al. Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Cancer Res 1990;50(15):4533-8
   PubMedGoogle Scholar
• Hamblin MR, Newman EL. On the mechanism of the tumour-localising effect in photodynamic therapy. J Photochem Photobiol B 1994;23(1):3-8
   PubMed Web of Science ®Google Scholar
• Steba Biotech NV; Brun PH, Prudhomme A, Barnoux J-L. Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same. EP1406616; 2004
   Google Scholar
• Chowdhary RK, Dolphin D. Drug delivery systems for photodynamic therapy. US2007086973; 2007
   Google Scholar
• Woodburn K, Chang CK, Lee S, et al. Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem Photobiol 1994;60(2):154-9
   PubMed Web of Science ®Google Scholar
• Cunderlikova B, Kongshaug M, Gangeskar L, Moan J. Increased binding of chlorin e6; to lipoproteins at low pH values. Int J Biochem Cell Biol 2000;32(7):759-68
   PubMedGoogle Scholar
• Mojzisova H, Bonneau S, Vever-Bizet C, Brault D. The pH-dependent distribution of the photosensitizer chlorin e6 among plasma proteins and membranes: a physico-chemical approach. Biochim Biophys Acta 2007;1768(2):366-74
   PubMed Web of Science ®Google Scholar
• Gullino PM, Grantham FH, Smith SH, Haggerty AC. Modifications of the acid-base status of the internal milieu of tumors. J Natl Cancer Inst 1965;34(6):857-69
   PubMedGoogle Scholar
• Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49(16):4373-84
   PubMed Web of Science ®Google Scholar
• Gal D, Ohashi M, MacDonald PC, et al. Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am J Obstet Gynecol 1981;139(8):877-85
   PubMed Web of Science ®Google Scholar
• Vitols S, Peterson C, Larsson O, et al. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res 1992;52(22):6244-7
   PubMed Web of Science ®Google Scholar
• Jori G, Beltramini M, Reddi E, et al. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett 1984;24(3):291-7
   PubMed Web of Science ®Google Scholar
• Bonneau S, Morliere P, Brault D. Dynamics of interactions of photosensitizers with lipoproteins and membrane-models: correlation with cellular incorporation and subcellular distribution. Biochem Pharmacol 2004;68(7):1443-52
   PubMedGoogle Scholar
• Silva JN, Filipe P, Morliere P, et al. Photodynamic therapies: principles and present medical applications. Biomed Mater Eng 2006;16(4 Suppl):S147-54
   PubMedGoogle Scholar
• Mojzisova H, Bonneau S, Vever-Bizet C, Brault D. Cellular uptake and subcellular distribution of chlorin e6 as functions of pH and interactions with membranes and lipoproteins. Biochim Biophys Acta 2007;1768(11):2748-56
   PubMed Web of Science ®Google Scholar
• Bonneau S, Vever-Bizet C, Mojzisova H, Brault D. Tetrapyrrole-photosensitizers vectorization and plasma LDL: a physico-chemical approach. Int J Pharm 2007;344(1-2):78-87
   PubMedGoogle Scholar
• Thomas JP, Girotti AW. Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative. Photochem Photobiol 1989;49(3):241-7
   PubMed Web of Science ®Google Scholar
• Cunderlikova B, Gangeskar L, Moan J. Acid-base properties of chlorin e6: relation to cellular uptake. J Photochem Photobiol B 1999;53(1-3):81-90
   PubMed Web of Science ®Google Scholar
• Bonneau S, Maman N, Brault D. Dynamics of pH-dependent self-association and membrane binding of a dicarboxylic porphyrin: a study with small unilamellar vesicles. Biochim Biophys Acta 2004;1661(1):87-96
   PubMedGoogle Scholar
• Henderson BW, Bellnier DA, Greco WR, et al. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res 1997;57(18):4000-7
   PubMedGoogle Scholar
• Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part two – cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2005;2:1-23
   PubMed Web of Science ®Google Scholar
• Henderson BW, Waldow SM, Mang TS, et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45(2):572-6
   PubMed Web of Science ®Google Scholar
• Korbelik M, Krosl G. Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply. Br J Cancer 1994;70(4):604-10
   PubMedGoogle Scholar
• Gomer CJ, Razum NJ. Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions. Photochem Photobiol 1984;40(4):435-9
   PubMed Web of Science ®Google Scholar
• Marchal S, Fadloun A, Maugain E, et al. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochem Pharmacol 2005;69(8):1167-76
   PubMed Web of Science ®Google Scholar
• Henderson BW, Busch TM, Vaughan LA, et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 2000;60(3):525-9
   PubMed Web of Science ®Google Scholar
• Dolmans DE, Kadambi A, Hill JS, et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002;62(15):4289-94
   PubMed Web of Science ®Google Scholar
• Abels C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem Photobiol Sci 2004;3(8):765-71
   PubMed Web of Science ®Google Scholar
• Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 1987;47(12):3110-4
   PubMed Web of Science ®Google Scholar
• Korbelik M, Krosl G, Krosl J, Dougherty GJ. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 1996;56(24):5647-52
   PubMed Web of Science ®Google Scholar
• Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 1995;71(3):549-55
   PubMed Web of Science ®Google Scholar
• Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 2002;62(6):1604-8
   PubMed Web of Science ®Google Scholar
• Xue LY, Chiu SM, Azizuddin K, et al. Protection by Bcl-2 against apoptotic but not autophagic cell death after photodynamic therapy. Autophagy 2008;4(1):125-7
   PubMed Web of Science ®Google Scholar
• Kessel D, Reiners JJ Jr. Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage. Photochem Photobiol 2007;83(5):1024-8
   PubMedGoogle Scholar
• Kessel D, Vicente MG, Reiners JJ Jr. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 2006;38(5):482-8
   PubMed Web of Science ®Google Scholar
• Kessel D, Vicente MG, Reiners JJ Jr. Initiation of apoptosis and autophagy by photodynamic therapy. Autophagy 2006;2(4):289-90
   PubMed Web of Science ®Google Scholar
• Kessel D, Reiners JJ Jr. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett 2007;249(2):294-9
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26(4):239-57
   PubMed Web of Science ®Google Scholar
• Dougherty TJ. Photodynamic therapy. Adv Exp Med Biol 1985;193:313-28
   PubMedGoogle Scholar
• Dellinger M. Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem Photobiol 1996;64(1):182-7
   PubMed Web of Science ®Google Scholar
• Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B 1998;42(2):89-95
   PubMedGoogle Scholar
• Kessel D, Luo Y. Intracellular sites of photodamage as a factor in apoptotic cell death. J Porphyr Phthalocyan 2001;5:181-4
   Google Scholar
• Plaetzer K, Kiesslich T, Krammer B, Hammerl P. Characterization of the cell death modes and the associated changes in cellular energy supply in response to AlPcS4-PDT. Photochem Photobiol Sci 2002;1(3):172-7
   PubMedGoogle Scholar
• Agarwal ML, Clay ME, Harvey EJ, et al. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 1991;51(21):5993-6
   PubMed Web of Science ®Google Scholar
• Dahle J, Kaalhus O, Moan J, Steen HB. Cooperative effects of photodynamic treatment of cells in microcolonies. Proc Natl Acad Sci USA 1997;94(5):1773-8
   PubMedGoogle Scholar
• Shao C, Furusawa Y, Kobayashi Y, et al. Bystander effect induced by counted high-LET particles in confluent human fibroblasts: a mechanistic study. FASEB J 2003;17(11):1422-7
   PubMed Web of Science ®Google Scholar
• Dummin H, Cernay T, Zimmermann HW. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains. J Photochem Photobiol B 1997;37(3):219-29
   PubMed Web of Science ®Google Scholar
• Morgan J, Potter WR, Oseroff AR. Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA-deficient derivative. Photochem Photobiol 2000;71(6):747-57
   PubMedGoogle Scholar
• Salet C, Moreno G. Photodynamic effects of haematoporphyrin on respiration and calcium uptake in isolated mitochondria. Int J Radiat Biol Relat Stud Phys Chem Med 1981;39(2):227-30
   PubMed Web of Science ®Google Scholar
• Salet C, Moreno G. Photosensitization of mitochondria. Molecular and cellular aspects. J Photochem Photobiol B 1990;5(2):133-50
   PubMed Web of Science ®Google Scholar
• Atlante A, Passarella S, Quagliariello E, et al. Haematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: inhibition of ADP/ATP translocator. J Photochem Photobiol B 1989;4(1):35-46
   PubMedGoogle Scholar
• Salet C, Moreno G, Ricchelli F, Bernardi P. Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore. J Biol Chem 1997;272(35):21938-43
   PubMedGoogle Scholar
• Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 2002;1(1):1-21
   PubMed Web of Science ®Google Scholar
• Berg K, Moan J. Lysosomes as photochemical targets. Int J Cancer 1994;59(6):814-22
   PubMed Web of Science ®Google Scholar
• Stoka V, Turk B, Schendel SL, et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001;276(5):3149-57
   PubMed Web of Science ®Google Scholar
• Kessel D, Luo Y, Deng Y, Chang CK. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem Photobiol 1997;65(3):422-6
   PubMed Web of Science ®Google Scholar
• Kessel D, Poretz RD. Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME). Photochem Photobiol 2000;71(1):94-6
   PubMedGoogle Scholar
• Lavie G, Kaplinsky C, Toren A, et al. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer 1999;79(3-4):423-32
   PubMed Web of Science ®Google Scholar
• Luo Y, Kessel D. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol 1997;66(4):479-83
   PubMedGoogle Scholar
• Ruck A, Kollner T, Dietrich A, et al. Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers. J Photochem Photobiol B 1992;12(4):403-12
   PubMed Web of Science ®Google Scholar
• Wood SR, Holroyd JA, Brown SB. The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light. Photochem Photobiol 1997;65(3):397-402
   PubMed Web of Science ®Google Scholar
• Teiten MH, Bezdetnaya L, Morliere P, et al. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br J Cancer 2003;88(1):146-52
   PubMed Web of Science ®Google Scholar
• Chen JY, Mak NK, Yow CM, et al. The binding characteristics and intracellular localization of temoporfin (mTHPC) in myeloid leukemia cells: phototoxicity and mitochondrial damage. Photochem Photobiol 2000;72(4):541-7
   PubMedGoogle Scholar
• Matroule JY, Hellin AC, Morliere P, et al. Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization. Photochem Photobiol 1999;70(4):540-8
   PubMedGoogle Scholar
• Kessel D. In vitro photosensitization with a benzoporphyrin derivative. Photochem Photobiol 1989;49(5):579-82
   PubMedGoogle Scholar
• Sailer R, Strauss WS, Emmert H, et al. Plasma membrane associated location of sulfonated meso-tetraphenylporphyrins of different hydrophilicity probed by total internal reflection fluorescence spectroscopy. Photochem Photobiol 2000;71(4):460-5
   PubMedGoogle Scholar
• Berg K, Western A, Bommer JC, Moan J. Intracellular localization of sulfonated meso-tetraphenylporphines in a human carcinoma cell line. Photochem Photobiol 1990;52(3):481-7
   PubMedGoogle Scholar
• MacDonald IJ, Morgan J, Bellnier DA, et al. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem Photobiol 1999;70(5):789-97
   PubMedGoogle Scholar
• Kessel D, Luguya R, Vicente MG. Localization and photodynamic efficacy of two cationic porphyrins varying in charge distributions. Photochem Photobiol 2003;78(5):431-5
   PubMedGoogle Scholar
• Krasnovsky AA Jr, Neverov KV, Egorov S, et al. Photophysical studies of pheophorbide a and pheophytin a. Phosphorescence and photosensitized singlet oxygen luminescence. J Photochem Photobiol B 1990;5(2):245-54
   PubMed Web of Science ®Google Scholar
• Kelbauskas L, Dietel W. Internalization of aggregated photosensitizers by tumor cells: subcellular time-resolved fluorescence spectroscopy on derivatives of pyropheophorbide-a ethers and chlorin e6 under femtosecond one- and two-photon excitations. Photochem Photobiol 2002;76(6):686-94
   PubMedGoogle Scholar
• Jori G, Reddi E, Cozzani I, Tomio L. Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. Br J Cancer 1986;53(5):615-21
   PubMed Web of Science ®Google Scholar
• Candide C, Morliere P, Maziere JC, et al. In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett 1986;207(1):133-8
   PubMed Web of Science ®Google Scholar
• Stein WD. Permeability for lipophilic molecules. Membrane transport: Elsevier; 1981. p. 1-128
   Google Scholar
• Kepczynski M, Pandian RP, Smith KM, Ehrenberg B. Do liposome-binding constants of porphyrins correlate with their measured and predicted partitioning between octanol and water? Photochem Photobiol 2002;76(2):127-34
   PubMed Web of Science ®Google Scholar
• Vever-Bizet C, Brault D. Kinetics of incorporation of porphyrins into small unilamellar vesicles. Biochim Biophys Acta 1993;1153(2):170-4
   PubMedGoogle Scholar
• Kuzelova K, Brault D. Kinetic and equilibrium studies of porphyrin interactions with unilamellar lipidic vesicles. Biochemistry 1994;33(32):9447-59
   PubMedGoogle Scholar
• Maman N, Dhami S, Phillips D, Brault D. Kinetic and equilibrium studies of incorporation of di-sulfonated aluminum phthalocyanine into unilamellar vesicles. Biochim Biophys Acta 1999;1420(1-2):168-78
   PubMed Web of Science ®Google Scholar
• Brault D, Vever-Bizet C, Le Doan T. Spectrofluorimetric study of porphyrin incorporation into membrane models - evidence for pH effects. Biochim Biophys Acta 1986;857(2):238-50
   PubMedGoogle Scholar
• Kuzelova K, Brault D. Interactions of dicarboxylic porphyrins with unilamellar lipidic vesicles: drastic effects of pH and cholesterol on kinetics. Biochemistry 1995;34(35):11245-55
   PubMedGoogle Scholar
• Bonneau S, Vever-Bizet C, Morliere P, et al. Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. Biophys J 2002;83(6):3470-81
   PubMedGoogle Scholar
• Wessels JM, Strauss W, Seidlitz HK, et al. Intracellular localization of meso-tetraphenylporphine tetrasulphonate probed by time-resolved and microscopic fluorescence spectroscopy. J Photochem Photobiol B 1992;12(3):275-84
   PubMed Web of Science ®Google Scholar
• Moan J, Berg K, Anholt H, Madslien K. Sulfonated aluminium phthalocyanines as sensitizers for photochemotherapy. Effects of small light doses on localization, dye fluorescence and photosensitivity in V79 cells. Int J Cancer 1994;58(6):865-70
   PubMed Web of Science ®Google Scholar